Annexon Inc (ANNX)
4.335
-0.02
(-0.57%)
USD |
NASDAQ |
May 17, 16:00
4.335
0.00 (0.00%)
After-Hours: 20:00
Annexon Cash from Operations (Quarterly): -28.27M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -28.27M |
December 31, 2023 | -23.48M |
September 30, 2023 | -28.29M |
June 30, 2023 | -36.38M |
March 31, 2023 | -32.99M |
December 31, 2022 | -27.14M |
September 30, 2022 | -30.72M |
June 30, 2022 | -28.16M |
March 31, 2022 | -30.29M |
December 31, 2021 | -28.32M |
September 30, 2021 | -29.72M |
Date | Value |
---|---|
June 30, 2021 | -24.63M |
March 31, 2021 | -23.44M |
December 31, 2020 | -19.26M |
September 30, 2020 | -13.58M |
June 30, 2020 | -10.25M |
March 31, 2020 | -10.00M |
December 31, 2019 | -8.789M |
September 30, 2019 | -6.87M |
June 30, 2019 | -6.696M |
March 31, 2019 | -6.003M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-36.38M
Minimum
Jun 2023
-6.696M
Maximum
Jun 2019
-22.36M
Average
-25.89M
Median
Cash from Operations (Quarterly) Benchmarks
Trxade Health Inc | -0.8675M |
P3 Health Partners Inc | -20.03M |
Arrowhead Pharmaceuticals Inc | -92.38M |
Insmed Inc | -184.04M |
Heron Therapeutics Inc | -9.516M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -77.30M |
Cash from Financing (Quarterly) | 32.41M |
Free Cash Flow | -116.42M |
Free Cash Flow Per Share (Quarterly) | -0.2304 |
Free Cash Flow Yield | -30.60% |